Journal article

Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

Sushrut Patil, Andrew Spencer, Anthony Schwarer, Sharon Avery, David Ritchie, Stephen Opat, Andrew Wei, Catriona McLean

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2009

DOI: 10.3109/10428190903288456

Citation metrics

2Scopus
1Dimensions

Keywords

Female
Autologous Stem Cell Transplantation
Elderly-Patients
Diffuse Large B Cell Lymphoma
Remission Induction
Middle Aged
Science & Technology
Impact
Germinal Center
Adult
Oncology
Non-Hodgkins-Lymphoma
Tissue Microarray
Hematology
Bone-Marrow-Transplantation
Lymphoma, Large B-Cell, Diffuse
Non-Germinal Centre
Cytarabine
Disease-Free Survival
Transplantation Conditioning
Treatment Outcome
Life Sciences & Biomedicine
Recurrence
Severity of Illness Index
Germinal Centre
Prognosis
Antineoplastic Combined Chemotherapy Protocols
Transplantation, Autologous
Male
Stem Cell Transplantation
Chemotherapy
Central Nervous System
High-Dose Therapy
B-Lymphocytes
Humans
Methotrexate
Retrospective Studies
Cns Involvement
Risk-Factors
Aged